Mentoring Multidisciplinary Patient-Oriented Research in Engagement in HIV Care
指导参与艾滋病毒护理的多学科、以患者为导向的研究
基本信息
- 批准号:9411533
- 负责人:
- 金额:$ 18.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAdvisory CommitteesAfricaAfricanAttentionCaringCase ManagementClinicClinic VisitsClinicalCommunitiesComplementComputerized Medical RecordCountryDataDatabasesEpidemicEpidemiologyEvaluationEventExhibitsFeedbackFoundationsFundingHIVHealthIncidenceIndividualInfectious Diseases ResearchInternationalInterventionInterviewInvestmentsK-Series Research Career ProgramsKenyaLeadMental disordersMentorsMentorshipMid-Career Clinical Scientist Award (K24)Midcareer Investigator Award in Patient-Oriented ResearchModelingOutcomeParentsPatient CarePatientsPatternPerceptionPersonsPlayPopulationPostdoctoral FellowProviderPublic HealthRNARandomizedResearchResearch ActivityResearch InfrastructureResearch PersonnelResourcesRisk FactorsRoleSamplingSan FranciscoScienceScientistSiteSocioeconomic StatusStudentsSubstance abuse problemSurveysSystemTimeTrainingTraining SupportUgandaUnited States Health Resources and Services AdministrationUnited States National Institutes of HealthUniversitiesViremiaVisitWorkZambiaZimbabwebasecareercohortdesignevidence baseexperiencefollow-uphealth care deliveryhousing instabilityimprovedmeetingsmultidisciplinarypatient oriented researchpre-doctoralpreventprogramspsychologicresiliencesafety netsenior facultyshared decision makingskillsstandard of caresuccesstreatment programvirologyward
项目摘要
Project Summary
I seek support from a K24 Award to build a mentoring program in patient oriented research to
enhance engagement in HIV treatment globally. At present, I lead robust research activities
supported by diverse mechanisms (including NIH R01 & U01, HRSA, and Gates Foundation)
with over 1.5 million dollars a year of direct funding. I am leading work in the US as well as
four African countries (Uganda, Kenya, Zimbabwe and Zambia), some within established
scientific networks (e.g., International Epidemiologic Databases to Evaluate AIDS). This
growing research portfolio has created abundant opportunities to mentor trainees, including
post-doctoral fellows supported by T32 and D43 mechanisms, pre-doctoral students, and those
from international partner organizations (e.g., Makerere University in Kampala). With support
from a K24 Award, I would offer a comprehensive but adaptable blueprint for mentorship, with a
focus on guiding investigators across two critical thresholds: first, for fellows establishing a
research career through obtaining a K23 Career Development Award, and second, sustaining a
research career through subsequent R01 level funding. My mentorship model is based both on
individual meetings as well as assembly of a team of mentors who can meet diverse technical,
professional and personal needs. In addition, within UCSF, I plan to integrate the proposed
mentoring with existing resources for training supported by the UCSF CTSI and the Center for
AIDS Research. Outside of UCSF, I will introduce mentees into flourishing research consortia
in which I am active (e.g., IeDEA and CNICS) as well as into public health implementing
organizations (e.g., Center for Infectious Disease Research in Zambia) where they can access
multi-site data and develop independent scientific projects and professional relationships. To
improve my mentoring, I will form an advisory committee of senior faculty at UCSF who will offer
feedback and evaluation on my mentoring using evidence-based metrics of success. At present,
I receive eight to ten requests for mentorship each year and have only been able to accept two
to three because my effort is fully taken by project specific research roles, clinical duties and
administrative obligations. Support from a K24 will allow me to accept up to eight total mentees
a year. This would include serving as primary mentor to 1 post-doctoral fellow and secondary
mentor to 2-3 fellows and other pre-doctoral residents and students. In particular, a K24 will
allow me to dedicate more time to the most intensive mentorship relationships with post doctoral
fellows competing for K23 Career Development Awards as well those seeking transition from
K23 to R01 level funding and full scientific independence.
项目概要
我寻求 K24 奖的支持,建立一个以患者为导向的研究指导计划,
加强全球艾滋病毒治疗的参与。目前,我领导着稳健的研究活动
得到多种机制的支持(包括 NIH R01 和 U01、HRSA 和盖茨基金会)
每年超过 150 万美元的直接资金。我在美国领导工作
四个非洲国家(乌干达、肯尼亚、津巴布韦和赞比亚),其中一些国家属于既定国家
科学网络(例如,评估艾滋病的国际流行病学数据库)。这
不断增长的研究组合为指导学员创造了丰富的机会,包括
T32、D43机制资助的博士后、博士前学生等
来自国际合作伙伴组织(例如坎帕拉的麦克雷雷大学)。有支持
从 K24 奖中,我将提供一个全面但适应性强的指导蓝图,其中包括:
重点是引导研究人员跨越两个关键门槛:首先,研究员建立一个
通过获得 K23 职业发展奖来促进研究生涯,其次,维持
研究生涯通过随后的 R01 级别资助。我的导师模式基于
单独的会议以及导师团队的集合,他们可以满足不同的技术、
专业和个人需求。此外,在 UCSF 内部,我计划整合拟议的
利用 UCSF CTSI 和中心支持的现有培训资源进行指导
艾滋病研究。在加州大学旧金山分校之外,我将向学员介绍蓬勃发展的研究联盟
我积极参与其中(例如 IeDEA 和 CNICS)以及公共卫生实施
他们可以访问的组织(例如赞比亚传染病研究中心)
多站点数据并开发独立的科学项目和专业关系。到
改善我的指导,我将组建一个由加州大学旧金山分校高级教师组成的咨询委员会,他们将提供
使用基于证据的成功指标对我的指导进行反馈和评估。现在,
我每年都会收到八到十个指导请求,但只能接受其中两个
到三,因为我的努力完全被项目特定的研究角色、临床职责和
行政义务。 K24 的支持将使我能够接受最多八名学员
一年。这将包括担任 1 名博士后研究员的主要导师和
指导 2-3 名研究员和其他博士前住院医师和学生。特别是,K24 将
让我能够将更多的时间投入到与博士后最密切的指导关系上
竞争 K23 职业发展奖的研究员以及寻求从
K23 至 R01 级别的资助和完全的科学独立性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elvin H. Geng其他文献
Developing ethical standards for dissemination and implementation research: a roadmap for consensus and guidance
制定传播和实施研究的道德标准:达成共识和指导的路线图
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Emmanuel K. Tetteh;Elvin H. Geng;Mark D. Huffman - 通讯作者:
Mark D. Huffman
Using stated preference methods to facilitate knowledge translation in implementation science
使用陈述偏好方法促进实施科学中的知识转化
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Whitney C. Irie;Andrew Kerkhoff;Hae;Elvin H. Geng;Ingrid Eshun - 通讯作者:
Ingrid Eshun
Dissemination and implementation research coordination and training to improve cardiovascular health in people living with HIV in sub-Saharan Africa: the research coordinating center of the HLB-SIMPLe Alliance
传播和实施研究协调和培训,以改善撒哈拉以南非洲艾滋病毒感染者的心血管健康:HLB-SIMPLe 联盟研究协调中心
- DOI:
10.1186/s43058-024-00599-4 - 发表时间:
2024-06-06 - 期刊:
- 影响因子:0
- 作者:
Emmanuel K. Tetteh;William Effah;L. Fuentes;Karen Steger;Charles W. Goss;David W Dowdy;Mark D. Huffman;Makeda J Williams;Veronica Tonwe;Geetha P Bansal;Elvin H. Geng;Victor G Davila;Treva Rice;Kenneth B Schechtman - 通讯作者:
Kenneth B Schechtman
Instrumental variables for implementation science: exploring context-dependent causal pathways between implementation strategies and evidence-based interventions
实施科学的工具变量:探索实施策略和循证干预措施之间依赖于背景的因果路径
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Aaloke Mody;Lindsey M Filiatreau;Charles W. Goss;Byron J Powell;Elvin H. Geng - 通讯作者:
Elvin H. Geng
Situating implementation science (IS) in res(IS)tance: a conceptual frame toward the integration of scholarship from the black radical tradition
将实施科学(IS)置于抵抗(IS)状态:黑人激进传统学术整合的概念框架
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:5.2
- 作者:
Cory D. Bradley;Whitney C. Irie;Elvin H. Geng - 通讯作者:
Elvin H. Geng
Elvin H. Geng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elvin H. Geng', 18)}}的其他基金
An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care II (ADAPT-R II)
预防和治疗成人 HIV 护理中保留失效的适应性策略 II (ADAPT-R II)
- 批准号:
10017320 - 财政年份:2019
- 资助金额:
$ 18.81万 - 项目类别:
An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care II (ADAPT-R II)
预防和治疗成人 HIV 护理中保留失效的适应性策略 II (ADAPT-R II)
- 批准号:
10239002 - 财政年份:2019
- 资助金额:
$ 18.81万 - 项目类别:
Mentoring Multidisciplinary Patient-Oriented Research in Engagement in HIV Care
指导参与艾滋病毒护理的多学科、以患者为导向的研究
- 批准号:
9517739 - 财政年份:2017
- 资助金额:
$ 18.81万 - 项目类别:
Mentoring Multidisciplinary Patient-Oriented Research in Engagement in HIV Care
指导参与艾滋病毒护理的多学科、以患者为导向的研究
- 批准号:
10190795 - 财政年份:2017
- 资助金额:
$ 18.81万 - 项目类别:
Adaptive Strategies for Preventing & Treating Lapses of Retention in Care (AdaPT)
适应性预防策略
- 批准号:
9315217 - 财政年份:2014
- 资助金额:
$ 18.81万 - 项目类别:
Adaptive Strategies for Preventing & Treating Lapses of Retention in Care (AdaPT)
适应性预防策略
- 批准号:
9102262 - 财政年份:2014
- 资助金额:
$ 18.81万 - 项目类别:
Adaptive Strategies for Preventing and Treating Lapses of Retention in Care (AdaPT)
预防和治疗护理保留失误的适应性策略 (AdaPT)
- 批准号:
9043547 - 财政年份:2014
- 资助金额:
$ 18.81万 - 项目类别:
Adaptive Strategies for Preventing & Treating Lapses of Retention in Care (AdaPT)
适应性预防策略
- 批准号:
8732203 - 财政年份:2014
- 资助金额:
$ 18.81万 - 项目类别:
Early Mortality in HIV Infected Patients Starting Antiretroviral Therapy in Afric
非洲开始抗逆转录病毒治疗的艾滋病毒感染者的早期死亡率
- 批准号:
8306796 - 财政年份:2009
- 资助金额:
$ 18.81万 - 项目类别:
Early Mortality in HIV Infected Patients Starting Antiretroviral Therapy in Afric
非洲开始抗逆转录病毒治疗的艾滋病毒感染者的早期死亡率
- 批准号:
7938686 - 财政年份:2009
- 资助金额:
$ 18.81万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686543 - 财政年份:2023
- 资助金额:
$ 18.81万 - 项目类别:
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709602 - 财政年份:2022
- 资助金额:
$ 18.81万 - 项目类别:
Children's Hospital Los Angeles Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
洛杉矶儿童医院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599558 - 财政年份:2022
- 资助金额:
$ 18.81万 - 项目类别: